Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omacor for Adipose Tissue Inflammation in Morbid Obesity
NCT00760760Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Sep 2008
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of omega-3-acid triglycerides in adipose tissue inflammation (ATI), sponsored by Medical University of Vienna. Started Sep 2008; status: completed.
02
Drugs
omega-3-acid triglycerides
03
Conditions
adipose tissue inflammation (ATI)
Beyond the preview
Go deeper on NCT00760760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00760760.